De-Risking Rare Pediatric Trials with Modeling and Operational Integration

Explore actionable insights for advancing pediatric rare disease programs through smarter design and integrated modeling approaches. 

Download the Infographic 

Developing therapies for pediatric rare diseases presents significant challenges including small, dispersed patient populations, sparse early data, and ethical constraints. To overcome these barriers, more efficient, patient-centered approaches to study design and execution are essential. 

This infographic explores how model-informed drug development can address these challenges and improve trial outcomes. It highlights: 

• Early integration of PK/PD modeling to inform dose selection and reduce uncertainty  
• Adaptive and flexible trial designs that enable more efficient study execution  
• Patient- and caregiver-centric approaches to enhance feasibility and engagement  
• Use of disease-specific site networks and registries to accelerate recruitment and strengthen data quality  
• Operational strategies that combine scientific rigor with executional efficiency  

Together, these elements provide a practical framework for designing faster, more predictable, and ethically sound pediatric rare disease trials. 

For more information on advancing pediatric rare disease programs, watch the recording of our webinar, Transforming Pediatric Rare Disease Trials Through Modeling and Simulation and Site Networks.